Understanding the Key Considerations & Analytical Methods to Ensure Product Safety in Cell & Gene Therapy

Time: 4:00 pm
day: Day 1 Track 1 PM


  • Describing potential strategy using the fit-for-purpose approach for selecting analytical methods at early stage of product development
  • Discussing selection of model systems for safety and efficacy testing for effective preclinical development
  • Reviewing tactics on engaging manufacturing partners to develop the phase I product